Automatic Website Traffic RSS

Orthostatic Hypotension Drug Updated with New Warnings

Orthostatic Hypotension Drug Updated with New Warnings. ... a norepinephrine prodrug, is indicated to treat symptomatic neurogenic orthostatic hypotension caused by primary autonomic failure ... read more

First Neurogenic Orthostatic Hypotension Drug OK’d in Two Decades

First Neurogenic Orthostatic Hypotension Drug OK’d in Two Decades The FDA has granted accelerated approval of Northera (droxidopa; Chelsea Therapeutics) for the treatment of symptomatic ... read more

Lundbeck Announces Availability of NORTHERA ... - Business Wire

“While the exact mechanism of action in the treatment of neurogenic orthostatic hypotension is unknown, NORTHERA is a prodrug that is directly metabolized to norepinephrine, the naturally ... read more

Chelsea Therapeutics Announces New Data from Northera Phase ... - Benzinga

Chelsea Therapeutics International, Ltd. CHTP announced that new data from Phase III trials in symptomatic neurogenic orthostatic hypotension demonstrating the activity and tolerability of ... read more

Chelsea Therapeutics Confirms Plan to File Northera NDA for the ...

CHARLOTTE, N.C., April 18, 2011 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) reaffirms NORTHERA™ (droxidopa) new drug application (NDA) filing strategy following ... read more

Renal Function and Sodium Metabolism in Idiopathic Orthostatic Hypotension

PATIENTS with idiopathic orthostatic hypotension demonstrate various hemodynamic abnormalities in response to standing. Reflex peripheral vasoconstriction fails to occur normally,1 venous return to ... read more

Theravance to Present Analyses of Ampreloxetine and Neurogenic ...

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced that analyses of the initial Phase 3 program of ampreloxetine (Studies 169 and 170) will be ... read more

PET Explains Orthostatic Hypotension in Parkinson's Disease - Medscape

NEW YORK (MedscapeWire) Apr 26 — A positron emission tomography (PET) study of 18 F fluorodopamine uptake, described in the April 23 issue of Neurology, sheds new light on orthostatic ... read more